The structured dose-escalation protocol used in the trial was specifically designed to mitigate gastrointestinal burden, and this approach is likely to inform any future prescribing guidance
This was presented at the American Diabetes Association meeting and suggests that mazdutide, through its glucagon receptor activation, drives significant hepatic fat reduction
Call your healthcare provider without delay if you experience persistent vomiting, severe diarrhea, severe abdominal pain, inability to pass gas or have bowel movements, dehydration, or jaundice (yellow discoloration of the skin and/or eyes)
The results are based on a web survey of 5,065 U.S
A medical professional will help you figure out a dosage that works best for your body and your unique health goals, as well as address any concerns you may have